Financial statements Mezopharma
Balance sheet of Mezopharma
Company age:
Age:
10 y. 8 m. 11 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of MEZOPHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 17 931,49 | 60 130,18 | 72 316,68 | 61 675,47 | 59 666,20 |
| A. Fixed assets | 1 000,00 | 1 000,00 | 1 000,00 | 1 000,00 | 1 000,00 |
| B. Current assets | 16 931,49 | 59 130,18 | 71 316,68 | 60 675,47 | 58 666,20 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 17 931,49 | 60 130,18 | 72 316,68 | 61 675,47 | 59 666,20 |
| A. Equity | -6 847,61 | 58 395,18 | 71 754,68 | 61 102,47 | 59 093,20 |
| B. Liabilities and provisions for liabilities | 24 779,10 | 1 735,00 | 562,00 | 573,00 | 573,00 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | - |
| II. Short-term liabilities | 24 779,10 | 1 735,00 | 562,00 | 573,00 | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.